79 results
SC 13E3/A
EX-99
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Going private transaction (amended)
9:16am
and, to the extent applicable, other Persons included in Parent Group to comply with the terms of this Agreement and shall be responsible to any breaches … of directors or responsible officers of the Rights Agent, shall determine that the action or proceedings so directed would involve the Rights Agent
8-K
EX-3.2
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Termination of a Material Definitive Agreement
9:13am
) such inability becomes known to the Secretary or an Assistant Secretary of the Company or to the transfer agent, or other person responsible for the giving
UPLOAD
STSA
Satsuma Pharmaceuticals Inc
23 May 23
Letter from SEC
12:00am
is responsible for the accuracy and
adequacy of its
disclosures, notwithstanding any review, comments, action or absence of action
by the staff
UPLOAD
STSA
Satsuma Pharmaceuticals Inc
23 May 23
Letter from SEC
12:00am
by Item 13 of
Schedule 13E-3.
We remind you that the filing persons are responsible for the accuracy
and adequacy of
their disclosures
10-K/A
EX-31.1
meplc4
28 Apr 23
Annual report (amended)
4:08pm
10-K/A
102v3iu lctbzuwbx
28 Apr 23
Annual report (amended)
4:08pm
10-K/A
EX-31.2
hiabo 6qjlclz
28 Apr 23
Annual report (amended)
4:08pm
8-K
EX-10.1
qyigpdqen90
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-1.1
p9c1s7 6ah03mm2u4
3 Nov 22
Entry into a Material Definitive Agreement
4:45pm
424B5
t05 l9559
3 Nov 22
Prospectus supplement for primary offering
4:42pm
UPLOAD
qjvw vx3530fs2zref
3 Nov 22
Letter from SEC
12:00am